Expression of microRNA-218 in breast cancer and its clinical significance
10.3969/j.issn.1006-5725.2017.15.021
- VernacularTitle:微小RNA-218在乳腺癌组织中的表达及临床意义
- Author:
Bo LIU
;
Like ZHANG
;
Zengren ZHAO
;
Yanfeng TIAN
;
Fang LI
;
Xiaodong HAN
- Keywords:
microRNA-218;
microRNAs;
gene expression;
prognosis;
Ki-67
- From:
The Journal of Practical Medicine
2017;33(15):2508-2511
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of miR-218 (microRNA-218) in breast cancer tissues and its clinical significance. Methods Totally 45 tissue biopsies gained from breast cancer patients and the adjacent normal tissue were collected. Real-time qPCR was used to detect the miR-218 expressions. The correlations of miR-218 expression with clinicopathological characteristics and prognosis of breast cancer patients were analyzed. Results The average expression level of miR-218 in breast cancer tissues was significantly lower than that in control tissues (P = 0.001). The average expression level of miR-218 in PR negative breast cancer tissues was significantly lower than that of PR positive breast cancer tissue (P = 0.037). The average expression level of miR-218 in Ki-67 positive breast cancer tissues was significantly lower than that in Ki-67 negative breast cancer tissue (P=0.018). Conclusion The expression of miR-218 is closely related to carcinogenesis ,progres-sion and prognosis of breast cancer ,so it may be served as a diagnostic biomarker and a prognostic predictor in breast cancer patients,which provides a new way for the treatment of breast cancer.
